Rock Springs Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.2M | Hold |
|
|||||
|
2025
Q1 | $31.3M | Sell |
|
|||||
|
2024
Q4 | $49.1M | Sell |
|
|||||
|
2024
Q3 | $51.8M | Buy |
|
|||||
|
2024
Q2 | $49.6M | Buy |
|
|||||
|
2024
Q1 | $54.1M | Hold |
|
|||||
|
2023
Q4 | $57.8M | Buy |
|
|||||
|
2023
Q3 | $40.2M | Hold |
|
|||||
|
2023
Q2 | $45.4M | Hold |
|
|||||
|
2023
Q1 | $42.2M | Buy |
|
|||||
|
2022
Q4 | $46.4M | Buy |
|
|||||
|
2022
Q3 | $41.7M | Buy |
|
|||||
|
2022
Q2 | $34.2M | Buy |
|
|||||
|
2022
Q1 | $25.8M | Buy |
|
|||||
|
2021
Q4 | $24.1M | Buy |
|
|||||
|
2021
Q3 | $8.91M | Buy |
|
|||||
|
2021
Q2 | $10.7M | Hold |
|
|||||
|
2021
Q1 | $10.2M | Buy |
|
|||||
|
2020
Q4 | $7.92M | Sell |
|
|||||
|
2020
Q3 | $5.71M | Hold |
|
|||||
|
2020
Q2 | $6.47M | Buy |
|
|||||
|
2020
Q1 | $5.67M | Buy |
|